FDA approves for Nemluvio (nemolizumab) for adult patients living with prurigo nodularis – Galderma
Galderma announced that the FDA has approved Nemluvio (nemolizumab) as a pre-filled pen for subcutaneous injection for the treatment of adults with prurigo nodularis. Nemluvio was granted Breakthrough… read more.